160 related articles for article (PubMed ID: 35004016)
1. Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.
Gladson V; Moosan H; Mathew S; P D
Cureus; 2021 Dec; 13(12):e20194. PubMed ID: 35004016
[TBL] [Abstract][Full Text] [Related]
2. An outbreak of Kyasanur forest disease in the Wayanad and Malappuram districts of Kerala, India.
Sadanandane C; Elango A; Marja N; Sasidharan PV; Raju KHK; Jambulingam P
Ticks Tick Borne Dis; 2017 Jan; 8(1):25-30. PubMed ID: 27692988
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India.
Sadanandane C; Gokhale MD; Elango A; Yadav P; Mourya DT; Jambulingam P
Exp Appl Acarol; 2018 May; 75(1):135-142. PubMed ID: 29594846
[TBL] [Abstract][Full Text] [Related]
4. A Case Series on the Spectrum of Complications Observed in Kyasanur Forest Disease.
Gladson V; Mathew S; J B; Aayilliath K A; Kumar P J; R S R
Cureus; 2024 May; 16(5):e59971. PubMed ID: 38854314
[TBL] [Abstract][Full Text] [Related]
5. The species distribution of ticks & the prevalence of Kyasanur forest disease virus in questing nymphal ticks from Western Ghats of Kerala, South India.
Balasubramanian R; Yadav PD; Sahina S; Nadh VA
Indian J Med Res; 2021 May; 154(5):743-749. PubMed ID: 35532592
[TBL] [Abstract][Full Text] [Related]
6. Kyasanur Forest Disease in India: innovative options for intervention.
Rajaiah P
Hum Vaccin Immunother; 2019; 15(10):2243-2248. PubMed ID: 30945970
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory profile of patients with Kyasanur forest disease: A single-centre study of 192 patients from Karnataka, India.
Gupta N; Chunduru K; Safeer K M; Saravu K
J Clin Virol; 2021 Feb; 135():104735. PubMed ID: 33493988
[TBL] [Abstract][Full Text] [Related]
8. Identification of bio-climatic determinants and potential risk areas for Kyasanur forest disease in Southern India using MaxEnt modelling approach.
Pramanik M; Singh P; Dhiman RC
BMC Infect Dis; 2021 Dec; 21(1):1226. PubMed ID: 34876036
[TBL] [Abstract][Full Text] [Related]
9. Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016.
Gurav YK; Yadav PD; Gokhale MD; Chiplunkar TR; Vishwanathan R; Patil DY; Jain R; Shete AM; Patil SL; Sarang GD; Sapkal GN; Andhare MD; Sale YR; Awate PS; Mourya DT
Vector Borne Zoonotic Dis; 2018 Mar; 18(3):164-172. PubMed ID: 29336707
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and ecological suitability analysis for potential tick vectors of Kyasanur forest disease in the Western Ghats of Kerala.
Rathinam B; Sidhik S
Med Vet Entomol; 2022 Mar; 36(1):38-42. PubMed ID: 34558682
[TBL] [Abstract][Full Text] [Related]
11. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019.
Munivenkatappa A; Yadav PD; Sahay RR; Sk K; Shete AM; Patil DY; Mohandas S; Jain R; Patil S; Sinha DP; Jayaswamy MM
Infect Dis (Lond); 2024 Feb; 56(2):145-156. PubMed ID: 37966909
[TBL] [Abstract][Full Text] [Related]
12. Does the rise in cases of Kyasanur forest disease call for the implementation of One Health in India?
Pattnaik S; Agrawal R; Murmu J; Kanungo S; Pati S
IJID Reg; 2023 Jun; 7():18-21. PubMed ID: 36941826
[TBL] [Abstract][Full Text] [Related]
13. Geospatial clustering, seasonal trend and forecasting of Kyasanur Forest Disease in the state of Goa, India, 2015-2018.
Oliveira A; Selvaraj K; Tripathy JP; Betodkar U; Cacodcar J; Quadros N; Wadkar A
Trop Med Health; 2020; 48():27. PubMed ID: 32355449
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease.
Yadav PD; Gurav YK; Shete AM; Jain R; Nyayanit DA; Pardeshi PG; Viswanathan R; Chiplunkar TR; Awate P; Majumdar TP; Sahay RR; Mourya DT
Indian J Med Res; 2019 Aug; 150(2):186-193. PubMed ID: 31670274
[TBL] [Abstract][Full Text] [Related]
15. On the transmission pattern of Kyasanur Forest disease (KFD) in India.
Murhekar MV; Kasabi GS; Mehendale SM; Mourya DT; Yadav PD; Tandale BV
Infect Dis Poverty; 2015 Aug; 4():37. PubMed ID: 26286631
[TBL] [Abstract][Full Text] [Related]
16. Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples.
Chaubal G; Sarkale P; Kore P; Yadav P
Heliyon; 2018 Feb; 4(2):e00549. PubMed ID: 29560461
[TBL] [Abstract][Full Text] [Related]
17. Kyasanur forest disease: a state-of-the-art review.
Gupta N; Wilson W; Neumayr A; Saravu K
QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of Kyasanur Forest disease: a retrospective cohort study from South India.
Gupta N; Nallapati VT; Chunduru K; Vithivattical ARJ; Kadavigere R; Saravu K
Trans R Soc Trop Med Hyg; 2022 Oct; 116(10):944-948. PubMed ID: 35355076
[TBL] [Abstract][Full Text] [Related]
19. Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease.
Majumdar T; Shete A; Yadav P; Patil S; Mali D; Waghmare A; Gawande P
Int J Infect Dis; 2021 Jul; 108():226-230. PubMed ID: 34023493
[TBL] [Abstract][Full Text] [Related]
20. Development of a clinical scoring system to make a presumptive diagnosis of Kyasanur Forest Disease: a case-control study from South India.
Gupta N; Boodman C; Saravu K
Infez Med; 2024; 32(1):61-68. PubMed ID: 38456026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
